FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN
For citations:
FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN. Pediatric pharmacology. 2024;21(3):295-296. (In Russ.)
Views:
164
Email this article 